Bedaquiline drug for multi-drug resistant TB

Q.  Bedaquiline drug is being tested to fight
- Published on 21 Feb 16

a. Malaria
b. Zika
c. Yellow fever
d. TB

ANSWER: TB
 
  • A pilot programme to test the toxicity, particularly cardio-toxicity, of bedaquiline drug (for combating multidrug- resistant TB) in the Indian population, to assess its ability to achieve culture conversion and to check the feasibility of using the drug to treat MDR-TB patients will start in India.
  • Only those resistant to both rifampicin and isoniazid, the first-line TB drugs, will be enrolled.
  • As per the WHO’s recommendation, bedaquiline will be given to patients, besides the regular multidrug treatment regimen. Unlike clinical trials, the six institutions will not enroll a certain number of patients each. Instead, patients willing to participate in the programme will be enrolled on a first come, first served basis.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲